K. Kitajima

发表

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

S. Mishiro, F. Tsuda, Y. Miyakawa, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Glomerulonephritis associated with arteritis in marmosets infected with hepatitis A virus.

M. Mayumi, H. Yoshizawa, M. Morita, 1981, British journal of experimental pathology.

[Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity].

M. Fukuoka, M. Takada, S. Kobayashi, 1987, Gan to kagaku ryoho. Cancer & chemotherapy.

Non-A, non-B (type 1) hepatitis agent capable of inducing tubular ultrastructures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat.

T. Tachibana, Y. Miyakawa, M. Mayumi, 1982, Gastroenterology.

Reaction of guanidines with .alpha.-diketones. Syntheses of 4,5-disubstituted-2-aminoimidazoles and 2,6-unsymmetrically substituted imidazo[4,5-d]imidazoles

K. Kitajima, T. Nishimura, 1979 .

A novel synthesis of 2-(disubstituted amino)-5(4)phenylimidazoles

S. Shibamoto, K. Kitajima, T. Nishimura, 1975 .

Light-harvesting heptadecameric porphyrin assemblies.

Toru Iwaki, Y. Kuroda, K. Sasaki, 2002, Journal of the American Chemical Society.

Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees.

Y. Miyakawa, M. Mayumi, H. Yoshizawa, 1981, Gastroenterology.

Viruslike particles in a plasma fraction (fibrinogen) and in the circulation of apparently healthy blood donors capable of inducing non-A/non-B hepatitis in humans and chimpanzees.

Y. Miyakawa, M. Mayumi, H. Yoshizawa, 1980, Gastroenterology.

Beta‐Propiolactone for the Inactivation of Non‐A/Non‐B Type 1 Hepatitis Virus Capable of Inducing Cytoplasmic Tubular Ultrastructures in Chimpanzees

Y. Miyakawa, H. Yoshizawa, T. Nakamura, 1984, Vox sanguinis.

Lack of detectable reverse transcriptase activity in human and chimpanzee sera with a high infectivity for non-A, non-B hepatitis.

Y. Miyakawa, M. Mayumi, T. Gotanda, 1986, The Journal of general virology.

Expanding the BBMRI-ERIC Directory into a Global Catalogue of COVID-19-Ready Collections: A Joint Initiative of BBMRI-ERIC and ISBER

T. Takagi, Toshihiro Tanaka, S. Imoto, 2020 .

Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan

W. Sugiura, H. Ohtsu, N. Ohmagari, 2021, International Journal of Infectious Diseases.

The Crystal and Molecular Structure of (±)-2-Methylamino-4,5-bis(p-chlorophenyl)-4-hydroxy-4H-imidazole

H. Ogura, H. Takayanagi, K. Kitajima, 1979 .